Dr. Andreas Jeromin Leading Panel on Identifying Biological Markers of Posttraumatic Stress Disorder at ISTSS 36th Annual Meeting, November 4-14
November 4, 2020Read moreOur Chief Scientific Officer Dr. Andreas Jeromin is leading a panel discussion at the ISTSS 37th Annual Meeting, titled “Identifying Biological Markers of Posttraumatic Stress Disorder (PTSD): Recent Findings and Efforts Across Modalities to Enhance Rigor and Robustness”.
New Research Partnership Pushes for Increased Transparency & Publication of Negative Research
November 2, 2020Read moreNull Hypothesis is a collaborative initiative dedicated to publishing well-performed replication and negative studies — or studies where the outcomes do not confirm expected results or working hypotheses — via dedicated journal space.
Neuron-Based Gene Expression Study Reveals Insights on Fear and Its Regulation
October 30, 2020Read moreWe’re proud to support a new study with our partner McLean Hospital exploring how the expression of a gene may function as a switch to regulate feelings of fear in psychiatric illnesses such as Post-Traumatic Stress Disorder (PTSD).
Join CVB and other researchers and clinicians at the virtual 10th Annual Traumatic Brain Injury Conference
October 27, 2020Read moreOur Chief Scientific Officer, Dr. Andreas Jeromin, is Chairing the conference on November 2-4, 2020 and will be joined by the CVB leadership team. Dr. Jeromin will be discussing recommendations from the Brain Trauma Blueprint 2019 State of the Science Summit.
Cohen Veterans Bioscience Virtually Attending & Exhibiting at the 2020 CNS Summit
October 23, 2020Read moreWe are excited to virtually attend and exhibit at the 2020 CNS Summit, October 29 – November 1, 2020.
This annual event convenes innovators across industry, academia, media, non-profit organizations, and others to enable networking, discussion, and collaboration in clinical development.
News
